208 related articles for article (PubMed ID: 34464587)
1. Lymphatic filariasis and visceral leishmaniasis coinfection: A review on their epidemiology, therapeutic, and immune responses.
Kushwaha V; Kaur S
Acta Trop; 2021 Dec; 224():106117. PubMed ID: 34464587
[TBL] [Abstract][Full Text] [Related]
2. Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India.
Singh AK; de Gooyer T; Singh OP; Pandey S; Neyaz A; Cloots K; Kansal S; Malaviya P; Rai M; Nylén S; Chakravarty J; Hasker E; Sundar S
PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011729. PubMed ID: 37903175
[TBL] [Abstract][Full Text] [Related]
3. Visceral leishmaniasis and HIV coinfection in Latin America.
Lindoso JA; Cota GF; da Cruz AM; Goto H; Maia-Elkhoury AN; Romero GA; de Sousa-Gomes ML; Santos-Oliveira JR; Rabello A
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3136. PubMed ID: 25233461
[TBL] [Abstract][Full Text] [Related]
4. Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia.
Franssen SU; Takele Y; Adem E; Sanders MJ; Müller I; Kropf P; Cotton JA
mBio; 2021 Jun; 12(3):e0097121. PubMed ID: 34182785
[TBL] [Abstract][Full Text] [Related]
5. Leishmania donovani molecules recognized by sera of filaria infected host facilitate filarial infection.
Verma R; Kushwaha V; Pandey S; Thota JR; Vishwakarma P; Parmar N; Yadav PK; Tewari P; Kar S; Shukla PK; Murthy PK
Parasitol Res; 2018 Sep; 117(9):2901-2912. PubMed ID: 29946763
[TBL] [Abstract][Full Text] [Related]
6. Treatment Options for Visceral Leishmaniasis and HIV Coinfection.
Monge-Maillo B; López-Vélez R
AIDS Rev; 2016; 18(1):32-43. PubMed ID: 26936761
[TBL] [Abstract][Full Text] [Related]
7. Implications of co-infection of Leptomonas in visceral leishmaniasis in India.
Selvapandiyan A; Ahuja K; Puri N; Krishnan A
Parasitology; 2015 Dec; 142(14):1657-62. PubMed ID: 26492813
[TBL] [Abstract][Full Text] [Related]
8. Visceral Leishmaniasis and HIV coinfection in East Africa.
Diro E; Lynen L; Ritmeijer K; Boelaert M; Hailu A; van Griensven J
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2869. PubMed ID: 24968313
[TBL] [Abstract][Full Text] [Related]
9. Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased
Cloots K; Marino P; Burza S; Gill N; Boelaert M; Hasker E
Front Cell Infect Microbiol; 2021; 11():604117. PubMed ID: 33777831
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment.
A AO; M MM; A HA; Elamin MY; Younis BM; E ME; Musa AM; Elhassan AM; G EA
Ann Saudi Med; 2014; 34(2):143-6. PubMed ID: 24894783
[TBL] [Abstract][Full Text] [Related]
11. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
12. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
Silva de Lima UR; Vanolli L; Moraes EC; Ithamar JS; Azevedo CMPES
PLoS One; 2019; 14(12):e0225875. PubMed ID: 31805100
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
Guedes DL; Justo AM; Barbosa Júnior WL; Silva EDD; Aquino SR; Lima Junior MSDC; Montarroyos U; Bezerra GSN; Vieira AVB; Pereira VRA; Medeiros ZM
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009067. PubMed ID: 33476331
[TBL] [Abstract][Full Text] [Related]
15. Clinical features, immunological interactions and household determinants of visceral leishmaniasis and malaria coinfections in West Pokot, Kenya: protocol for an observational study.
van Dijk N; Carter J; Omondi W; Mens P; Schallig H
BMJ Open; 2023 Apr; 13(4):e068679. PubMed ID: 37068901
[TBL] [Abstract][Full Text] [Related]
16. Leishmaniasis in Sudan. Visceral leishmaniasis.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
[TBL] [Abstract][Full Text] [Related]
17. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
Bhattacharyya T; Bowes DE; El-Safi S; Sundar S; Falconar AK; Singh OP; Kumar R; Ahmed O; Boelaert M; Miles MA
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
[TBL] [Abstract][Full Text] [Related]
20. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
